ZyVersa Therapeutics Inc. Financial Flexibility Index
ZyVersa Therapeutics Inc. financial flexibility index. ZyVersa Therapeutics Inc. (ZVSA) has a Financial Flexibility Index of -110.21x as of September 2025. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -110% of total liabilities ($12.77 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ZyVersa Therapeutics Inc. (2020–2024)
Financial flexibility index of ZyVersa Therapeutics Inc. from 2020 to 2024. Historical Financial Flexibility Index trend for ZyVersa Therapeutics Inc. across 5 annual periods. Explore ZyVersa Therapeutics Inc. (ZVSA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
ZyVersa Therapeutics Inc. Financial Flexibility Index by Year (2020–2024)
ZyVersa Therapeutics Inc. financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for ZyVersa Therapeutics Inc.. For the full cash flow conversion analysis, see ZVSA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | $-7.56 Million | $-7.56 Million | $12.08 Million | ▲ +20.8% |
| 2023 | -0.79x | $-8.72 Million | $-8.72 Million | $11.04 Million | ▼ -199.1% |
| 2022 | -0.26x | $-4.89 Million | $-4.89 Million | $18.51 Million | ▲ +29.1% |
| 2021 | -0.37x | $-5.08 Million | $-5.08 Million | $13.63 Million | ▲ +32.6% |
| 2020 | -0.55x | $-5.11 Million | $-5.11 Million | $9.24 Million | — |